Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / Ordinary Shares, par value NIS 0.10 per share
-
Shares outstanding
-
1,147,663,152
-
Total 13F shares
-
595,232,782
-
Share change
-
-4,582,206
-
Total reported value
-
$29,899,759,479
-
Put/Call ratio
-
63%
-
Price per share
-
$50.23
-
Number of holders
-
803
-
Value change
-
-$270,337,135
-
Number of buys
-
339
-
Number of sells
-
371
Institutional Holders of TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.10 per share (TEVA) as of Q2 2016
As of 30 Jun 2016,
TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.10 per share (TEVA) was held by
803 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
595,232,782 shares.
The largest 10 holders included
FMR LLC, FRANKLIN RESOURCES INC, Viking Global Investors LP, BARROW HANLEY MEWHINNEY & STRAUSS LLC, WADDELL & REED FINANCIAL INC, Capital Research Global Investors, PAULSON & CO. INC., LAZARD ASSET MANAGEMENT LLC, PointState Capital LP, and Bank of New York Mellon Corp.
This page lists
803
institutional shareholders reporting positions in this security
for the Q2 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.